The Oncology Institute, Inc. (NASDAQ:TOI) Short Interest Up 70.1% in November

The Oncology Institute, Inc. (NASDAQ:TOI) was the target of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 421,900 shares, a growth of 70.1% from the October 31st total of 248,000 shares. Based on an average daily trading volume, of 1,010,000 shares, the short-interest ratio is presently 0.4 days. Approximately 1.1% of the company’s shares are short sold.

Hedge Funds Weigh In On Oncology Institute

Several large investors have recently bought and sold shares of TOI. HighTower Advisors LLC lifted its holdings in Oncology Institute by 190.8% in the third quarter. HighTower Advisors LLC now owns 81,362 shares of the company’s stock valued at $27,000 after buying an additional 53,382 shares during the period. Renaissance Technologies LLC lifted its holdings in Oncology Institute by 142.3% in the second quarter. Renaissance Technologies LLC now owns 339,400 shares of the company’s stock valued at $156,000 after buying an additional 199,300 shares during the period. Finally, Tiff Advisory Services LLC lifted its holdings in Oncology Institute by 235.1% in the second quarter. Tiff Advisory Services LLC now owns 1,418,685 shares of the company’s stock valued at $653,000 after buying an additional 995,280 shares during the period. 36.86% of the stock is currently owned by institutional investors and hedge funds.

Oncology Institute Trading Down 4.7 %

NASDAQ TOI traded down $0.01 during trading hours on Friday, hitting $0.16. The company’s stock had a trading volume of 1,117,426 shares, compared to its average volume of 416,743. The stock has a fifty day moving average of $0.28 and a 200 day moving average of $0.40. Oncology Institute has a twelve month low of $0.13 and a twelve month high of $2.50. The firm has a market capitalization of $12.24 million, a P/E ratio of -0.21 and a beta of 0.60. The company has a quick ratio of 2.27, a current ratio of 2.49 and a debt-to-equity ratio of 5.91.

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.